Nicotine Science and Policy

By Harry Shapiro Aug. 13, 2026

Harry's blog 134: Filtering out lies and misinformation

The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.

September 08, 2026 by consideratepouchers.org

New Zealand decided to legalise pouches. Then nothing happened.

Legalising nicotine pouches was never supposed to cause a public health spectacle. New Zealand’s experience suggests that regulated access can simply give adult smokers another smoke-free option without the chaos often predicted by opponents. That matters because fear-based arguments frequently assume the worst before a product is even allowed to operate under rules. Sensible regulation can manage risk while still making room for alternatives that help move people away from cigarettes.


World map



September 08, 2026 by gfn.tv

What Does the Science Tell Us About Heated Tobacco Products? | #GFN26ScienceLab

The science on heated tobacco products sits in the space between cigarette harm and smoke-free innovation. These products still involve tobacco, but they do not burn it in the same way cigarettes do, making exposure data and real-world switching patterns essential. The key is not to overstate certainty or ignore risk, but to understand where they sit on the nicotine risk spectrum. Better regulation starts with that comparison.



September 07, 2026 by quitlikesweden.org

The Three A's: Why Access Decides Who Quits Smoking, and Who Doesn't

Access can decide whether quitting smoking is realistic or only recommended. Safer nicotine alternatives need to be available, affordable and acceptable enough for adult smokers to actually use them. Sweden’s experience shows the importance of meeting people with practical options, not just warnings about harm. Public health progress depends on making the route away from combustion easier to take.


World map

September 07, 2026 by substack.com

Laura Hunter’s Tobacco Defence Does Not Survive Scrutiny

Dismissing harm reduction as “tobacco defence” is an easy way to avoid the harder question: what actually helps smokers leave cigarettes behind? Industry scrutiny remains necessary, but it cannot replace evidence on combustion, switching and relative risk. A debate that treats every safer nicotine product as a corporate trick leaves no room for consumer experience or measurable reductions in harm. Public health should be able to challenge tobacco companies without dismissing the tools that may make cigarettes less dominant.



September 07, 2026 by tobaccoinsider.com

Tobacco Regulation: Asia

Asia’s nicotine regulation is moving in many directions at once: tighter cigarette controls, new rules for vapes, disputes over pouches and continued pressure from illicit trade. That patchwork matters because adult smokers do not experience policy as a regional trend; they experience it as access, price, risk information and legal certainty. Regulation that ignores product differences can protect cigarettes by default. A stronger approach would recognise local realities while keeping the goal clear: less smoking, less combustion and fewer preventable harms.


World map

Categories:


Blogs

Harry's blog 134: Filtering out lies and misinformation

The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.

Harry’s blog 133: Silence is consent

Two tobacco control consultations that demand your attention

I’m sure there are many of you like me who are deeply cynical about public consultations. They often feel like political tick box exercises allowing the issuing authority from local councils to international organisations to say they have ‘consulted with the people’, when in truth they knew exactly what they were going to do from the get-go.

Harry’s Blog 132: “Zyn! Went The Strings Of My Heart” (with apologies to Judy Garland)

FDA approval of 20 nicotine pouch products is another step forward for tobacco harm reduction

The FDA in the U.S. has granted marketing authorisation for Zyn nicotine pouch products (five variations on mint plus five other flavours in two different strengths).

In its letter to PMI (who own Zyn manufacturers Swedish Match), the FDA wrote:

Based on our review of your MRTPAs [Modified Risk Tobacco Applications] we determined that the proposed modified risk tobacco products, …as actually used by consumers would significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products. Therefore, we authorize marketing of the tobacco products as modified risk tobacco products with the following modified risk information – “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis”.